empower compounded tirzepatide Announcing semaglutide and PRICE DROP! We are excited to announce that our prices with Pharmacy are going DOWN for semaglutide and tirzepatide. Starting April 1st, we will be changing some Sharing for those who are

Patients taking diabetes medications alongside Saxenda and fluoxetine may require adjustments to their treatment regimen

The SURPASS trials showed triglyceride reductions of 19-25%, which is comparable to what some dedicated lipid-lowering medications achieve

Regional Insights North America GLP-1 Receptor Agonist Market Insights North America dominated the global GLP-1 Receptor Agonist Market in 2025 with approximately 45% of global revenues, anchored entirely by the United States' unique drug pricing environment and the commercial investment that Novo Nordisk and Eli Lilly have made in building GLP-1 prescribing across endocrinology, primary care, cardiology, and bariatric medicine

Call our office today for more information about how LAK MedSpa can help you achieve your goals or to schedule an appointment